Nature Research Round Table: Regulations Around Human Induced Pluripotent Stem Cell Registration
Dr. Andreas Kurtz from the Berlin-Brandenburg Center for Regenerative Therapies discusses data associated with human pluripotent stem cells (hPSCs) as well as the benefits of and regulations around data registration for cell line characterization. Since 2010, Dr. Kurtz has managed hPSCreg, a freely accessible global registry for human hPSC lines. This presentation and the following Q&A session were moderated by Dr. Joanne Mountford from the University of Glasgow.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Dr. Andreas Kurtz from the Berlin-Brandenburg Center for Regenerative Therapies discusses data associated with human pluripotent stem cells (hPSCs) as well as the benefits of and regulations around data registration for cell line characterization. Since 2010, Dr. Kurtz has managed hPSCreg, a freely accessible global registry for human hPSC lines. This presentation and the following Q&A session were moderated by Dr. Joanne Mountford from the University of Glasgow.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Publish Date:
November 01, 2019
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Data Quality and Standards for Pluripotent Stem Cells
Publish Date: September 28, 2018 -
Nature Research Round Table: HLA Typing Considerations for Human Pluripotent Stem Cell Banking
Publish Date: November 01, 2019 -
Nature Research Round Table: Defining and Maintaining Pluripotency & hPSC Line Registration and Banking - Panel Discussion
Publish Date: November 01, 2019
Explore Our Products
-
Healthy Control Human iPSC Line, Female, SCTi003-A
Human pluripotent stem cell line, frozen -
cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells -
Serum-free cryopreservation medium for human ES and iPS cells -
qPCR analysis kit for detecting the majority of karyotypic abnormalities reported in human ES and iPS cells
